Biological
Haemophilus Influenzae B Vaccine clinical trials
- studies test it
- 5
- open now
- 0
- in phase 3
- 4
- first study started
- 2006
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2006 (1)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2018 | 1 |
| 2019 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 1
- Phase 3
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 0
LG Life Sciences (2) · Sanofi Pasteur, a Sanofi Company (1) · Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd (1) · GlaxoSmithKline (1)
Often tested with
Tested in the same studies.
13-valent pneumococcal vaccine (1) · RotaTeq (1) · Hepatitis B Vaccines (1) · Chickenpox Vaccine (1)
Studies
Open first, then newest update. How each study uses Haemophilus Influenzae B Vaccine is read from its arms, and is right about nine times in ten.
Testing it · 5
- Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and ToddlersCompletedPhase 3Sanofi Pasteur, a Sanofi CompanyNCT03691610Written as Haemophilus b Conjugate Vaccine
- Immunogenicity and Safety of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 3 Months to 5 Years OldCompletedPhase 2Beijing Zhifei Lvzhu Biopharmaceutical Co., LtdNCT04865497Written as Haemophilus b Conjugate Vaccine
- Immuno & Safety Study With 2 Formulations of DTPw-HBV/HIB When Given at Birth With Hepatitis B at 2, 4 and 6 Mths.Age.TerminatedPhase 3GlaxoSmithKlineNCT00316680Written as Diphtheria, tetanus, pertussis, hepatitis B, Hib vaccine
- Immunogenicity and Safety Study of 4th LBVH0101 After the Primary Vaccination in LG-VHCL002 StudyCompletedPhase 3LG Life SciencesNCT01251133Written as LBVH0101 (Hib vaccine)
- Immunogenicity and Safety Study of LBVH0101 in Healthy Infants at Two, Four and Six Months of AgeCompletedPhase 3LG Life SciencesNCT01019772Written as LBVH0101 (Hib vaccine)
Given in every arm · 2 — Haemophilus Influenzae B Vaccine is usual care beside what is tested
- Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049)CompletedPhase 3GlaxoSmithKlineNCT01345240Written as Infanrix/Hib™ vaccine
- Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy InfantsCompletedPhase 3NovartisNCT00806195Written as Hib (Haemophilus influenza b) Vaccine
As the comparator · 5 — what is tested is compared with Haemophilus Influenzae B Vaccine
- Confirmatory Study of BK1310 in Healthy InfantsCompletedPhase 3Tanabe Pharma CorporationNCT03891758Written as Hib vaccine
- Phase 3 Study of BK1310 in Healthy InfantsCompletedPhase 3Tanabe Pharma CorporationNCT02992925Written as Hib vaccine
- PCV7 in the Prevention of Nasopharyngeal Carriage of Vaccine Serotype (VT) Streptococcus PneumoniaeCompletedNot applicableCenters for Disease Control and Prevention, ChinaNCT02133469Written as Hib Vaccine
- Phase 3 Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate VaccineCompletedPhase 3Jiangsu Province Centers for Disease Control and PreventionNCT01580033Written as Hib vaccine
- Immunogenicity and Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Infants and ChildrenCompletedPhase 3Jiangsu Province Centers for Disease Control and PreventionNCT01428908Written as Hib vaccine